These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 9499457

  • 21. Effects of antisense p21 (WAF1/CIP1/MDA6) expression on the induction of differentiation and drug-mediated apoptosis in human myeloid leukemia cells (HL-60).
    Freemerman AJ, Vrana JA, Tombes RM, Jiang H, Chellappan SP, Fisher PB, Grant S.
    Leukemia; 1997 Apr; 11(4):504-13. PubMed ID: 9096690
    [Abstract] [Full Text] [Related]

  • 22. Modulation of ara-C induced apoptosis in leukemia by the PKC activator bryostatin 1.
    Grant S.
    Front Biosci; 1997 Jun 01; 2():d242-52. PubMed ID: 9195893
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
    Cartee L, Wang Z, Decker RH, Chellappan SP, Fusaro G, Hirsch KG, Sankala HM, Dent P, Grant S.
    Cancer Res; 2001 Mar 15; 61(6):2583-91. PubMed ID: 11289135
    [Abstract] [Full Text] [Related]

  • 27. Modulation of 1-[beta-D-arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C.
    Grant S, Turner AJ, Bartimole TM, Nelms PA, Joe VC, Jarvis WD.
    Oncol Res; 1994 Mar 15; 6(2):87-99. PubMed ID: 7949469
    [Abstract] [Full Text] [Related]

  • 28. Differential effects of phorbol ester on apoptosis in HL-60 promyelocytic leukemia cells.
    Zhu WH, Loh TT.
    Biochem Pharmacol; 1996 May 03; 51(9):1229-36. PubMed ID: 8645347
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation.
    Szallasi Z, Denning MF, Smith CB, Dlugosz AA, Yuspa SH, Pettit GR, Blumberg PM.
    Mol Pharmacol; 1994 Nov 03; 46(5):840-50. PubMed ID: 7969070
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effect of a combined exposure to cytosine arabinoside, bryostatin 1, and recombinant granulocyte-macrophage colony-stimulating factor on the clonogenic growth in vitro of normal and leukemic human hematopoietic progenitor cells.
    Grant S, Traylor R, Bhalla K, McCrady C, Pettit GR.
    Leukemia; 1992 May 03; 6(5):432-9. PubMed ID: 1593908
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. 1alpha,25-dihydroxyvitamin D3 and bryostatin-1 synergize to induce monocytic differentiation of NB4 acute promyelocytic leukemia cells by modulating cell cycle progression.
    Clark CS, Konyer JE, Meckling KA.
    Exp Cell Res; 2004 Mar 10; 294(1):301-11. PubMed ID: 14980523
    [Abstract] [Full Text] [Related]

  • 36. Effect of bryostatin 1 on taxol-induced apoptosis and cytotoxicity in human leukemia cells (U937).
    Wang S, Guo CY, Castillo A, Dent P, Grant S.
    Biochem Pharmacol; 1998 Sep 01; 56(5):635-44. PubMed ID: 9783732
    [Abstract] [Full Text] [Related]

  • 37. Evidence of a functional role for the cyclin-dependent kinase inhibitor p21CIP1 in leukemic cell (U937) differentiation induced by low concentrations of 1-beta-D-arabinofuranosylcytosine.
    Wang Z, Wang S, Fisher PB, Dent P, Grant S.
    Differentiation; 2000 Aug 01; 66(1):1-13. PubMed ID: 10997587
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effects of bryostatins 1 and 2 on morphological and functional differentiation of SH-SY5Y human neuroblastoma cells.
    Jalava AM, Heikkilä J, Akerlind G, Pettit GR, Akerman KE.
    Cancer Res; 1990 Jun 01; 50(11):3422-8. PubMed ID: 2334938
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.